Table 1.
The most abundant bioactive factors determined by Ray Biotech protein assay analysis in the secretome of lytic HCMV-infected cells.
Cell types |
||||||
---|---|---|---|---|---|---|
Classification | Symbol | Gene annotation | Biological function | NHDF1 | HUVEC2 | LEC3 |
Cytochine/chemochine | CXCL1; GROα | Chemokine (C-X-C motif) ligand 1 | Chemoattractant for neutrophils | • | • | • |
CXCL5; ENA-78 | Chemokine (C-X-C motif) ligand 5 | Recruitment and activation of leukocytes | • | • | ||
CXCL6; GCP-2 | Chemokine (C-X-C motif) ligand 6 | Chemoattractant for neutrophilic granulocytes | • | |||
CXCL9; MIG | Chemokine (C-X-C motif) ligand 9 | Leukocyte trafficking | • | |||
CXCL10; IP-10 | Chemokine (C-X-C motif) ligand 10 | Stimulation of monocytes, natural killer, and T-cell migration | • | • | ||
CXCL11; I-TAC | Chemokine (C-X-C motif) ligand 11 | Chemoattractant | • | • | • | |
CXCL16 | Chemokine (C-X-C motif) ligand 16 | Recruitment of leukocytes | • | • | ||
CCL1; I-309 | Chemokine (C-C motif) ligand 1 | Leukocyte trafficking | • | |||
CCL3; MlP-1α | Chemokine (C-C motif) ligand 3 | Inflammatory responses | • | • | ||
CCL4; MlP-1β | Chemokine (C-C motif) ligand 4 | Chemokinetic and inflammatory functions | • | • | • | |
CCL5; RANTES | Chemokine (C-C motif) ligand 5 | Chemoattractant for blood monocytes, memory T helper cells and eosinophils | • | • | ||
CCL7; MCP-3 | Chemokine (C-C motif) ligand 7 | Chemoattractant for macrophages | • | • | • | |
CCL8; MCP-2 | Chemokine (C-C motif) ligand 8 | Leukocyte trafficking | • | • | ||
CCL15; MIP-1δ | Chemokine (C-C motif) ligand 15 | T-cells and monocyte chemoattractant | • | |||
CCL20; MIP-3α | Chemokine (C-C motif) ligand 20 | Leukocyte trafficking | • | • | • | |
CCL23; MPIF-1 | Chemokine (C-C motif) ligand 23 | Chemotactic activity on resting T lymphocytes and monocytes | • | |||
IL-1α | Interleukin-1α | Role in immune responses and inflammatory processes | • | |||
IL-3 | Interleukin-3 | Role in cell growth, differentiation, and apoptosis | • | |||
IL-5 | Interleukin-5 | Growth and differentiation factor for B cells and eosinophils | • | • | ||
IL-6 | Interleukin-6 | Anti-inflammatory cytokine | • | • | • | |
IL-8 | Interleukin-8 | Leukocyte trafficking | • | • | ||
IL-10 | Interleukin-10 | Anti-inflammatory cytokine | • | |||
IL-13 | Interleukin-13 | Anti-inflammatory cytokine | • | |||
IL-15 | Interleukin-15 | T and natural killer cells activation and proliferation | • | |||
LTA; TNF-β | Lymphotoxin A | Proinflammatory cytokine | • | |||
TNF-α | Tumor necrosis factor alpha | Proinflammatory cytokine | • | • | ||
Osteoprotegerin | PG/TNFRSF11B | Lymph-node organogenesis and vascular calcification | • | • | ||
Growth factor | GM-CSF | Granulocyte-Macrophage Colony-Stimulating-Factor | Bone and cartilagine development | • | • | • |
bFGF | Fibroblast Growth Factor 2 (basic) | Mitogenic and angiogenic activities | • | |||
TGF-β1 | Transforming growth factor beta 1 | Cell growth, proliferation, differentiation, adhesion, and migration | • | • | ||
HGF | Hepatocyte growth factor | Angiogenesis | • | |||
Receptor | ICAM-1 | Intercellular adhesion molecule 1 | Cell adhesion for endothelial and immune system cells | • | • | • |
TNF-RI | Tumor necrosis factor receptor 1 | Regulator of inflammation | • | • | ||
TNF-RII | Tumor necrosis factor receptor 2 | Regulator of inflammation | • | |||
ECM | MMP-1 | Matrix metallopeptidase 1 | Disruption of extracellular matrix | • | • | |
TIMP-1 | TIMP metallopeptidase inhibitor 1 | Inhibitor of the matrix metalloproteinases | • | |||
TIMP-2 | TIMP metallopeptidase inhibitor 2 | Inhibitor of the matrix metalloproteinases | • | |||
TIMP-4 | TIMP metallopeptidase inhibitor 4 | Inhibitor of the matrix metalloproteinases | • | |||
Enzyme | ANG | Angiogenin, ribonuclease, RNase A family, 5 | Angiogenesis | • |